p38 and TNF alpha inhibitors (Pharmacopeia)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38 and TNF alpha inhibitors (Pharmacopeia)
Drug Alias NamePS-166276PS-826957PS-200981
ClassificationSmall molecules
Mechanisms of ActionTumor necrosis factor α inhibitorsP38 α mitogen-activated protein kinase inhibitors
TargetsTumor necrosis factor αP38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacopeia Llc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A